BRAF and metastatic malignant neoplasm in the lymph nodes: There was no significant difference in miR-20a expression level by BRAF mutation status (p = 0.62) or extent of disease (p = 0.70 for tumor size; p = 0.12 for lymph node metastasis) in DTC or PTC.